Stablecoin Development Corporation earnings releases SDEV

Stablecoin Development Corporation last reported quarterly results on Oct 5, 2026, for Q3 FY2026 (the quarter ended Sep 30, 2026): revenue of $2.1 million and diluted EPS of $0.23. It usually reports 5–31 days after a quarter ends. Based on that pattern, the next release is estimated for around Jan 15, 2027.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 5–31 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Oct 5, 2026
5 days after quarter end
Q3 FY2026
ended Sep 30, 2026
2
50
+3995.1%
0.23
+120.9%
Jul 31, 2026
31 days after quarter end
Q2 FY2026
ended Jun 30, 2026
2
-41
-2036.8%
-1.32
+20.0%
Apr 6, 2026
6 days after quarter end
Q1 FY2026
ended Mar 31, 2026
2
552
+7102.1%
3.33
-53.0%
Oct 16, 2024
16 days after quarter end
Q3 FY2024
ended Sep 30, 2024
0
-100.0%
-1
+31.0%
—
Jul 11, 2024
11 days after quarter end
Q2 FY2024
ended Jun 30, 2024
2
-32.1%
-2
+22.2%
—
Mar 14, 2024
74 days after quarter end
—
ended Dec 31, 2023
—
—
—
Jul 21, 2020
21 days after quarter end
—
ended Jun 30, 2020
—
—
—
Jul 29, 2019
29 days after quarter end
—
ended Jun 30, 2019
—
—
—

Company profile

Industry
Finance Services (SIC 6199)
Listed as
SDEV (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
West Palm Beach, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1389545
Former names
NovaBay Pharmaceuticals, Inc. (until Mar 23, 2026)

Other Finance Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.